Bluspring Enterprises Secures ₹1,437.17 Crore O&M Order from Vedanta Aluminium
Bluspring Enterprises Limited, through its step-down subsidiary STEAG Energy Services, has secured a major operations and maintenance contract from Vedanta Aluminium Metal Limited. The five-year agreement, valued at ₹1,437.17 crore, focuses on a massive 1,215 MW captive power facility.
Adani Enterprises Launches QIP at Floor Price of ₹3,034.68 Per Share
Adani Enterprises has initiated a Qualified Institutions Placement (QIP) on July 2, 2026, following formal board and shareholder approvals. The company has set a floor price of ₹3,034.68 per share to raise capital from institutional investors for its diversified business operations.
Belrise Industries Secures Shareholder Approval for ₹2,000 Crore Fundraise via QIP
Belrise Industries Limited has received overwhelming shareholder approval to raise up to ₹2,000 crore through a Qualified Institutions Placement (QIP). The special resolution, passed via postal ballot with a 99.82% majority, authorizes the company to issue equity shares or equity-linked instruments to institutional investors.
RattanIndia Subsidiary Revolt Motors Launches RVX Electric Bike at ₹1.24 Lakh
Revolt Motors, a subsidiary of RattanIndia Enterprises, has introduced the RVX, its most powerful electric motorcycle to date. The model features a 5.3 kW peak power output and a 160 km range, targeting the performance-oriented urban commuter segment.
HEC Infra Projects Secures ₹48 Crore Work Order from Bharat Petroleum for Pipeline Project
HEC Infra Projects has secured a significant ₹48 crore domestic contract from Bharat Petroleum Corporation Limited for high-voltage electrical infrastructure. The project supports the Vadinar-Bina Crude Pipeline expansion and is scheduled for completion within nine months.
Iris Clothings Launches Newborn Gift Set Range to Expand Premium Infant Wear Portfolio
Iris Clothings Limited has officially entered the high-potential newborn gifting segment with a new range of curated apparel sets. This expansion leverages the company's integrated manufacturing model and a multi-channel distribution strategy to capture growth in the premium infant wear market.
Glenmark Pharmaceuticals Advances Phase 3 Trial for Trastuzumab rezetecan in Ovarian Cancer
Glenmark Specialty S.A. has advanced its multi-country Phase 3 clinical trial for Trastuzumab rezetecan, a HER2-targeted antibody-drug conjugate. India marks the initial site for patient enrollment following DCGI approval, with further expansion planned for Australia and South Korea.
JSW Infrastructure Completes Landmark ₹7,503 Crore QIP to Fund Mega Expansion
JSW Infrastructure Limited has successfully concluded a ₹7,503 crore Qualified Institutions Placement, marking a milestone in the Indian industrial sector. The capital raised will support a massive ₹39,000 crore multi-year expansion program and facilitate regulatory compliance regarding public shareholding.
Bayer AG to Acquire 11.91% Stake in Bayer CropScience via ₹2,374 Crore Block Deal
Bayer AG has entered an agreement to acquire an 11.91% stake in Bayer CropScience Ltd from fellow promoter Bayer CropScience AG. The transaction, valued at approximately ₹2,374 crore, will be executed via a block deal mechanism on or after July 8, 2026.